Literature DB >> 26926974

Aortic Stenosis: Diagnosis and Treatment.

Brian H Grimard1, Robert E Safford1, Elizabeth L Burns1.   

Abstract

Aortic stenosis affects 3% of persons older than 65 years. Although survival in asymptomatic patients is comparable to that in age- and sex-matched control patients, it decreases rapidly after symptoms appear. During the asymptomatic latent period, left ventricular hypertrophy and atrial augmentation of preload compensate for the increase in afterload caused by aortic stenosis. As the disease worsens, these compensatory mechanisms become inadequate, leading to symptoms of heart failure, angina, or syncope. Aortic valve replacement is recommended for most symptomatic patients with evidence of significant aortic stenosis on echocardiography. Watchful waiting is recommended for most asymptomatic patients. However, select patients may also benefit from aortic valve replacement before the onset of symptoms. Surgical valve replacement is the standard of care for patients at low to moderate surgical risk. Transcatheter aortic valve replacement may be considered in patients at high or prohibitive surgical risk. Patients should be educated about the importance of promptly reporting symptoms to their physicians. In asymptomatic patients, serial Doppler echocardiography is recommended every six to 12 months for severe aortic stenosis, every one to two years for moderate disease, and every three to five years for mild disease. Cardiology referral is recommended for all patients with symptomatic moderate and severe aortic stenosis, those with severe aortic stenosis without apparent symptoms, and those with left ventricular systolic dysfunction. Medical management of concurrent hypertension, atrial fibrillation, and coronary artery disease will lead to optimal outcomes.

Entities:  

Mesh:

Year:  2016        PMID: 26926974

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  12 in total

Review 1.  Oxidative Stress in Calcific Aortic Valve Stenosis: Protective Role of Natural Antioxidants.

Authors:  Radhika Adhikari; Saugat Shiwakoti; Ju-Young Ko; Bikalpa Dhakal; Sin-Hee Park; Ik Jun Choi; Hyun Jung Kim; Min-Ho Oak
Journal:  Antioxidants (Basel)       Date:  2022-06-14

Review 2.  Resolution-promoting autacoids demonstrate promising cardioprotective effects against heart diseases.

Authors:  Roddy Hiram
Journal:  Mol Biol Rep       Date:  2022-02-10       Impact factor: 2.742

3.  Impact of frailty on health-related quality of life 1 year after transcatheter aortic valve implantation.

Authors:  Jeannette A Goudzwaard; Marjo J A G de Ronde-Tillmans; Fleurance E D van Hoorn; Eline H C Kwekkeboom; Mattie J Lenzen; Maarten P H van Wiechen; Joris F W Ooms; Rutger-Jan Nuis; Nicolas M Van Mieghem; Joost Daemen; Peter P T de Jaegere; Francesco U S Mattace-Raso
Journal:  Age Ageing       Date:  2020-10-23       Impact factor: 10.668

4.  Educational Case: Aortic Valve Stenosis.

Authors:  Nolan G Schwarz; Walter L Kemp
Journal:  Acad Pathol       Date:  2020-10-08

5.  Serum miR-222 is independently associated with atrial fibrillation in patients with degenerative valvular heart disease.

Authors:  Hualan Zhou; Sen Lin; Xia Li; Dianxuan Guo; Yun Wang; Youdong Hu
Journal:  BMC Cardiovasc Disord       Date:  2021-02-16       Impact factor: 2.298

6.  Association between serum cystatin C level and hemodynamically significant aortic stenosis: a prospective cohort study.

Authors:  Odong Christopher; Xing-Feng Xu; Yi-Fen Lin; Shao-Zhao Zhang; Yi-Quan Huang; Xiang-Bin Zhong; Zhen-Yu Xiong; Tara Scarlett Rosalyn Chen; Chao-Guang Xu; Xiao-Dong Zhuang; Xin-Xue Liao
Journal:  J Geriatr Cardiol       Date:  2021-12-28       Impact factor: 3.327

7.  Predictors of Mortality Following Aortic Valve Replacement in Aortic Stenosis Patients.

Authors:  Vladimir Shvartz; Maria Sokolskaya; Andrey Petrosyan; Artak Ispiryan; Sergey Donakanyan; Leo Bockeria; Olga Bockeria
Journal:  Pathophysiology       Date:  2022-03-09

Review 8.  A systematic review of micro-RNAs in aortic stenosis and cardiac fibrosis.

Authors:  Jemima Osekafore Adewuyi; Roshan Patel; Riccardo Abbasciano; Gerry P McCann; Gavin Murphy; Marcin J Woźniak; Anvesha Singh
Journal:  Clin Transl Sci       Date:  2022-05-21       Impact factor: 4.438

9.  Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis in people with low surgical risk.

Authors:  Ahmed A Kolkailah; Rami Doukky; Marc P Pelletier; Annabelle S Volgman; Tsuyoshi Kaneko; Ashraf F Nabhan
Journal:  Cochrane Database Syst Rev       Date:  2019-12-20

10.  Aortic valve replacement: validation of the Toronto Aortic Stenosis Quality of Life Questionnaire.

Authors:  Derk Frank; Simon Kennon; Nikolaos Bonaros; Lukas Stastny; Mauro Romano; Thierry Lefèvre; Carlo Di Mario; Pierluigi Stefàno; Flavio Ribichini; Dominique Himbert; Marina Urena-Alcazar; Jorge Salgado-Fernandez; Jose Joaquin Cuenca Castillo; Bruno Garcia Del Blanco; Cornelia Deutsch; Lenka Sykorova; Jana Kurucova; Martin Thoenes; Claudia M Lüske; Peter Bramlage; Rima Styra
Journal:  ESC Heart Fail       Date:  2020-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.